FGF19 and gallbladder cancer: A recent Japanese study showed that FGF19 gene amplification is detected in 3% of the overall BTC patient population (260 cases, including 145 iCCA), and it was more frequently observed in iCCA compared with extrahepatic CCA and gallbladder cancer [5].